Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Last year's invitation to shareholder meeting

was dated Nov 30. Has anyone heard from investor relations (Cliff) about this year's proxy and when shareholders might expect it?

Share
New Message
Please login to post a reply